Acer Therapeutics Inc.
Boston, MA
- UEI
- C6EKP8VELDC1
- CAGE
- 76BR6
- Primary NAICS
- 456110 Pharmacies and Drug Retailers
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 101 Federal St 29th floor, Boston, MA 02110, USA
- Website
- zevra.com
- Founded
- 2006
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract vehicles
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | Florham Park, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| Astor Drugs | Holtsville, NY | 325412 Pharmaceutical Preparation Manufacturing |
| Soleno Therapeutics Inc. | Redwood City, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Ascendis Pharma, Inc. | — | 325412 Pharmaceutical Preparation Manufacturing |
| GC Biopharma Usa, Inc. | Teaneck, NJ | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Acer Therapeutics Inc. is a for-profit corporate entity registered in the System for Award Management (SAM.gov) since July 19, 2014, with its registration valid until February 24, 2026. The company specializes in pharmaceutical products, focusing on the development and distribution of drugs and medical treatments, particularly in the areas of hematology and specific pharmaceutical medications. Their primary federal contract offerings center on the provision of specialized pharmaceutical products, with a specific focus on medications like MIPLYFFA and OLPRUVA, which are supplied to federal agencies through various contracting mechanisms.
The company has secured multiple Federal Supply Schedule (FSS) contract IDVs, primarily through the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. These contracts include a $1,891,583.25 Blanket Purchase Agreement with the National Acquisition Center for MIPLYFFA and OLPRUVA, awarded on July 8, 2025, with a performance period through July 7, 2026. Additionally, Acer Therapeutics holds two contracts with the Veterans Integrated Service Network 12 (VISN 12): a $225,000 multiple-award FSS contract from January 1, 2024, to December 31, 2028, for drugs, pharmaceuticals, and hematology-related products, and a previous $25,000 interim agreement under Schedule 65 I B that ran through December 31, 2023. These contracts demonstrate the company's ability to provide pharmaceutical products to federal agencies through pre-negotiated pricing and terms, with no specific set-asides applied to the contracts.
Quick answers
Is Acer Therapeutics Inc. registered in SAM.gov?
Yes. Acer Therapeutics Inc.'s SAM.gov registration is active through August 28, 2027.
What is Acer Therapeutics Inc.'s CAGE code?
Acer Therapeutics Inc.'s CAGE code is 76BR6, and its Unique Entity ID (UEI) is C6EKP8VELDC1.
Which contract vehicles does Acer Therapeutics Inc. hold?
Acer Therapeutics Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
On GovTribe
See Acer Therapeutics Inc.'s full federal record
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors